Helex Raises $3.5 Mn To Develop Targeted Medicines For Genetic Kidney Diseases

Share via:


SUMMARY

The seed funding round was led by pi Ventures, with participation from a host of investors, including Bluehill.VC, US-based SOSV, among others

The startup will deploy the capital to accelerate pre-clinical development of its lead programme —- developing a drug to cure patients suffering from Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Founded  in 2021, Helex is developing advanced medicines for curing genetic kidney diseases via gene and cell therapy 

Biotech startup Helex has raised $3.5 Mn (around INR…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Helex Raises $3.5 Mn To Develop Targeted Medicines For Genetic Kidney Diseases


SUMMARY

The seed funding round was led by pi Ventures, with participation from a host of investors, including Bluehill.VC, US-based SOSV, among others

The startup will deploy the capital to accelerate pre-clinical development of its lead programme —- developing a drug to cure patients suffering from Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Founded  in 2021, Helex is developing advanced medicines for curing genetic kidney diseases via gene and cell therapy 

Biotech startup Helex has raised $3.5 Mn (around INR…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

It’s been 8 years of phone AI chips —...

It’s been a little over eight years since we...

Get Up to $200 Off M5 iPad Pro on...

Amazon this weekend is offering discounts across the M5...

This highly-rated portable monitor is now under $67

If you travelling abroad or visiting a friend's home,...

Popular

iptv-portugal iptv-portugal iptv-portugal iptv-portugal